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We present a patient with tenofovir disoproxil fumarate
(TDF)-induced Fanconi syndrome, osteomalacia and
concurrent nucleos(t)ide reverse transcriptase inhibitor
related CD4 cell decline. Sequentially measured intracel-
lular (ic) tenofovir-diphosphate (TFV-DP) levels were
extremely high, with plasma TFV just slightly elevated.
In June 2008 a 53-year-old Caucasian male com-
plained of severe pain in his lower extremities. He was
diagnosed with HIV in 1995 and developed some poly-
neuropathy and severe lipoatrophy after initiation of
ART in 1996. In September 2003 TDF 300 mg qd, dida-
nosine (ddI) 250 mg qd and lopinavir-ritonavir (LPV-r)
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from 136 to 489/mm
3 by December 2007, but then
slowly decreased to 181 despite a persistently undetect-
able HIV-1 RNA. There was 13 kg weight loss when he
developed diabetes mellitus in April 2008. In May 2008
blood and urinalysis were compatible with Fanconi syn-
drome. Creatinine clearance (CCl) had decreased from
76 (2003) to 44 mL/min (GC). Serum 1,25(OH)-vitamin
D was low (20 pmol/L), but 25(OH)-vitamin D and
PTH were normal. MRI of feet and knees showed pat-
chy bone marrow oedema without fractures, DXA
demonstrated osteopenia and bone biopsy confirmed
the diagnosis osteomalacia. While CCl decreased,
plasma TFV increased only slightly (from 0.23 in July
2004 to 0.36 mg/mL in September 2008), but ic TFV-
DP levels were found to be extremely high, 3630 fmol/
10
6 cells (mean TFV-DP in patients on LPV-r 233.1
fmol/10
6 cells [1]). Eight weeks after TDF dose reduc-
tion and 2 weeks after TDF cessation ic TFV-DP was
still high (310 fmol/10
6 cells), but plasma TFV was
undetectable, illustrating the long ic half-life. Ic dideoxy
adenosine-triphosphate (ddATP) levels were also high,
123 fmol/10
6 cells (n 5.06 fmol/10
6 cells) as were ddI
plasma levels (max. 0.304 mg/L). TDF and ddI were
replaced by raltegravir/nevirapine and phosphate, cal-
cium and 1,25(OH)2-VitD temporarily supplemented.
Two months later symptoms disappeared, CCl improved
to 62 mL/min, CD4s increased (286 cells/mm
3) and oral
antidiabetics could be stopped.
This case illustrates the severe clinical impact of pro-
tracted unrecognised TDF-related toxicity and is sugges-
tive of a causal relationship between TDF use,
concomitant factors and ic TFV-DP accumulation (fig
1). A significant CD4 cell decline in patients with unde-
tectable HIV-RNA on TDF- and/or ddI-containing ART
should alert the physician to investigate for NRTI
toxicity.
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